Trump says gold will not face tariffs
"Gold will not be Tariffed!" Trump said in a statement posted on his social media account and attributed to the president.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Owens & Minor Inc (OMI) Q2 2025 Earnings Call Highlights: Navigating Growth Amid Challenges
Revenue: $682 million for Q2 2025, a 3.3% increase from Q2 2024. Adjusted EBITDA: $96.6 million for Q2 2025, with a margin rate of 14.2%. Adjusted Net Income: $20.5 million or $0.26 per share for Q2 2025. Net Debt: $1.9 billion as of June 30, 2025. Cash Flow from Operating Activities: $38 million for Q2 2025. Projected Full-Year Revenue: Between $2.76 billion and $2.82 billion for 2025. Projected Full-Year Adjusted EBITDA: Between $376 million and $382 million for 2025. Projected Full-Year Adjusted Net Income per Share: Between $1.02 and $1.07 for 2025. Warning! GuruFocus has detected 2 Warning Sign with OMI. Release Date: August 11, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Owens & Minor Inc (NYSE:OMI) is in the final stages of divesting its Products and Healthcare Services segment, allowing it to focus on the higher-margin, higher-growth Patient Direct business. The Patient Direct segment has shown significant growth, with projected revenue between $2.76 billion and $2.82 billion and adjusted EBITDA between $376 million and $382 million for 2025. The company is capitalizing on demographic shifts and macroeconomic trends that drive increased demand for home-based healthcare. Owens & Minor Inc (NYSE:OMI) has a strong culture of disciplined growth, focusing on both organic initiatives and strategic acquisitions. The company has successfully improved its revenue cycle operations and collection rates, contributing to a strong cash flow quarter with significant working capital reduction. Negative Points The divestiture process has led to stranded costs, which impacted adjusted EBITDA by approximately $11 million in the second quarter of 2025. The termination of the Rotech acquisition resulted in $80 million in expenses and $18 million in related financing costs, affecting the company's financials. Revenue growth for the quarter was lower than expected due to supplier disruptions in diabetes supplies, impacting customer ordering quantities and delivery frequency. The company faces potential future pressure from competitive bidding in the diabetes segment, although the full impact is uncertain. Interest expenses remain a concern, with Owens & Minor Inc (NYSE:OMI) responsible for cash interest obligations of both continuing and discontinued operations. Q & A Highlights Q: How long will the elevated level of stranded costs persist after the transaction closure, and how quickly can they be reduced? A: Jonathan Leon, CFO, stated that the $11 million in stranded costs from Q2 is a good near-term annualized run rate. If the deal closes before the end of the year, they expect to see a reduction in these costs by the back half of 2026. Q: What is the medium-term trajectory for the diabetes business, and how will competitive bidding impact it? A: Jonathan Leon, CFO, mentioned that the shift from DME to pharmacy will continue, albeit at a slower rate. They are focusing on growing their pharmacy channel. Competitive bidding is still early, and they are not heavily exposed to Medicare rates, which are less than 20% of their revenue. Q: Can you provide insights into the potential sale price or multiple for the Products and Healthcare Services segment? A: Jonathan Leon, CFO, indicated that it is difficult to read through the current assets versus liabilities held for sale to determine the sale price. They are actively engaged in the process and remain diligent and thorough. Q: How will the perceived loss of the Kaiser contract affect growth in 2026? A: Edward Pesicka, CEO, explained that the impact will be limited in 2025, with most of the transition occurring in 2026. While top-line growth may be affected, they see opportunities to drive stronger bottom-line growth by utilizing existing assets and equipment. Q: What factors contributed to the Patient Direct revenue growth in the quarter, and what is the outlook for the second half? A: Jonathan Leon, CFO, noted that despite supplier disruptions affecting diabetes supplies, sleep, ostomy, and urology categories showed strong growth. They expect similar growth in the second half, with some rebound in diabetes. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
7 minutes ago
- Yahoo
Warren Buffett Just Issued a $344 Billion Ominous Warning to Wall Street -- but Are Investors Paying Attention?
Key Points The Oracle of Omaha has crushed the benchmark S&P 500 over the last 60 years, which is why so many investors follow his every move. Buffett's investing prowess is his gift, which makes Berkshire Hathaway's rising cash balance all the more ominous. Patience tends to be one of Buffett's most-powerful investing tools. 10 stocks we like better than Berkshire Hathaway › Wall Street is chock-full of recognizable analysts and fund managers. However, none has the ability to garner the attention of professional and everyday investors quite like the Oracle of Omaha, Warren Buffett. Since grabbing the reins as CEO of Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) 60 years ago, Buffett has overseen a 5,637,640% cumulative return in his company's Class A shares (BRK.A), as of the closing bell on Aug. 8. When you handily outperform the benchmark S&P 500 (SNPINDEX: ^GSPC) -- the S&P 500 has gained approximately 42,500%, including dividends, over six decades -- you're bound to be noticed. But as an investor, you have to learn to take the bad with the good. While investors frequently look to Berkshire's billionaire boss for ideas as to which stocks to buy, a seemingly unstoppable stock market rally has them overlooking a $344 billion ominous warning Buffett just issued. The Oracle of Omaha's warning to Wall Street is unmistakable Berkshire Hathaway's more than 5,600,000% gain spanning six decades didn't occur by accident. It's a reflection of Buffett and his team, which included trusted right-hand man Charlie Munger until his passing in November 2023, laying the foundation for a business that can thrive in virtually any economic climate. Since taking the lead role, the Oracle of Omaha has overseen in the neighborhood of five dozen acquisitions. He's also responsible for managing a $293 billion portfolio, which is spread across more than three dozen stocks. It's this portfolio that investors eye like a hawk. Buffett has snagged some incredible deals hiding in plain sight during his tenure as CEO. Apple, Bank of America (NYSE: BAC), American Express, and Coca-Cola have individually generated tens of billions of dollars in unrealized gains, to go along with bountiful dividend income. There's an expectation from investors that Berkshire's billionaire chief will continue to put his company's treasure chest to work in great businesses. However, this expectation has fallen flat for nearly three years -- and it serves as an unmistakable warning to the investing community. When Berkshire Hathaway lifted the hood on its quarterly operating results on Aug. 2, the company's cautious tone on tariffs took center stage. But there's another figure in Berkshire's report that's far more ominous and telling: $344.1 billion. This is the total cash, cash equivalents, and U.S. Treasuries Berkshire Hathaway had on its balance sheet when June ended. Though this figure is actually 1% below the all-time high of $347.7 billion in cash, cash equivalents, and U.S. Treasuries reported at the end of March, it's more than triple the $105.4 billion that was on the balance sheet when June 2022 came to a close. While positive operating cash flow from Berkshire's roughly five dozen owned businesses has provided a boost to the company's mammoth cash pile, being a net seller of stocks for 11 consecutive quarters, to the tune of $177.4 billion, is the primary culprit. Berkshire Hathaway's growing cash pile is plain-as-day evidence that Buffett is struggling to find value amid a historically pricey stock market. Buffett's favorite valuation measure, the market-cap-to-GDP ratio (commonly known as the "Buffett Indicator"), hit an all-time of more than 210% in late July, which represents a nearly 150% premium to its average reading when back-tested to 1970. Berkshire's $344 billion treasure chest is a not-so-subtle warning from Buffett that premium stock valuations probably aren't sustainable. Patience is one of the most-powerful tools on Wall Street There's certainly justification to the premise that stocks are incredibly pricey, beyond just the Buffett Indicator. The S&P 500's Shiller price-to-earnings (P/E) ratio, which is also known as the cyclically adjusted P/E Ratio, or CAPE Ratio, hit its third-priciest multiple during a continuous bull market when back-tested 154 years! It's truly become challenging to find price dislocations on Wall Street. Though some investors are probably irritated by the Oracle of Omaha's lack of buying activity since October 2022, being patient and waiting for stock valuations to fall into his wheelhouse is a foundational aspect of Buffett's investing strategy. Spanning 60 years, Buffett has seen a lot. He's navigated his fair share of bubbles and premium valuation events, as well as numerous bear markets and a handful of stock market crashes. Throughout these ebbs-and-flows, he's stuck to his thesis of never betting against America and has focused his attention on buying stakes in great businesses at a fair price. At the end of the day, Buffett and his investment team are well aware that the U.S. economy and stock market tend to grow over time, which is why Berkshire Hathaway's investment portfolio is angled to take advantage of these disproportionately long periods of economic growth. One of the best examples of Buffett's patience paying off handsomely for his company occurred in the summer of 2011. Shortly after the depths of the financial crisis, Berkshire's chief infused $5 billion into Bank of America in return for BofA preferred stock that yielded 6% annually. Though $300 million in annual dividend income was great, the real value in this deal was the BofA stock warrants Berkshire received. During the summer of 2017, Berkshire exercised its warrants for 700 million shares of Bank of America common stock at $7.14/share. The day these warrants were exercised, Berkshire enjoyed a $12 billion windfall -- and shares of BofA have continued to climb since these shares were purchased. Though there's uncertainty as to when Buffett or CEO successor Greg Abel will put a good chunk of Berkshire Hathaway's capital to work, there's no mistaking that this patient approach has been fruitful for the company and its shareholders. Should you invest $1,000 in Berkshire Hathaway right now? Before you buy stock in Berkshire Hathaway, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Berkshire Hathaway wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 11, 2025 American Express is an advertising partner of Motley Fool Money. Bank of America is an advertising partner of Motley Fool Money. Sean Williams has positions in Bank of America. The Motley Fool has positions in and recommends Apple and Berkshire Hathaway. The Motley Fool has a disclosure policy. Warren Buffett Just Issued a $344 Billion Ominous Warning to Wall Street -- but Are Investors Paying Attention? was originally published by The Motley Fool
Yahoo
7 minutes ago
- Yahoo
Gold Holds Loss as Traders Seek Clarity on Trump's No-Tariff Vow
(Bloomberg) -- Gold held a loss after President Donald Trump said imports of bullion won't be subject to US tariffs, although traders were still waiting for formal clarification over the policy following a federal ruling last week that sowed chaos and confusion across the market. Spot gold held near $3,345 an ounce on Tuesday, following a 1.6% drop on in the previous session after Trump posted 'Gold will not be Tariffed!' on social media. Futures of the precious metal in New York edged lower, after a 2.5% plunge on Monday. Invest in Gold American Hartford Gold: #1 Precious Metals Dealer in the Nation Priority Gold: Up to $15k in Free Silver + Zero Account Fees on Qualifying Purchase Thor Metals Group: Best Overall Gold IRA Sunseeking Germans Face Swiss Backlash Over Alpine Holiday Congestion New York Warns of $34 Billion Budget Hole, Biggest Since 2009 Crisis To Head Off Severe Storm Surges, Nova Scotia Invests in 'Living Shorelines' Chicago Schools' Bond Penalty Widens as $734 Million Gap Looms A New Stage for the Theater That Gave America Shakespeare in the Park US Customs and Border Protection stunned traders last week by ruling the imports would be subject to duties. The shock led futures on New York's Comex to surge more than $100 an ounce above benchmark spot prices in London on Friday. The spread has since narrowed to about $50. Washington's decision regarding gold tariffs has sweeping implications for the flow of bullion around the world, and potentially for the smooth functioning of the US futures contract. The administration had exempted the precious metal from duties in April, and until there is long-term clarity, traders say, precious metals markets will remain on edge. Gold has climbed more than a quarter this year, with the bulk of those gains occurring in the first four months. It's been supported by geopolitical and trade tensions that have spurred haven demand, along with strong central bank purchases. Elsewhere, the dollar held a gain ahead of a US inflation report due later Tuesday that may offer clues on the Federal Reserve's monetary policy path. Higher rates are negative for non-interest bearing gold, while a stronger greenback tends to make the dollar-denominated commodity more expensive for most buyers. Investors were also weighing Trump's move on Monday to extend a tariff truce on Chinese goods for another 90 days into early November. The move should ease worries of a renewed trade war between the two biggest economies, reducing haven demand. Spot gold rose 0.1% to $3,345.12 an ounce as of 8:15 a.m. in London. The Bloomberg Dollar Spot Index dipped 0.1%, after posting a 0.3% gain on Monday. Silver advanced, palladium was flat, while platinum fell. Why It's Actually a Good Time to Buy a House, According to a Zillow Economist Bessent on Tariffs, Deficits and Embracing Trump's Economic Plan The Social Media Trend Machine Is Spitting Out Weirder and Weirder Results Klarna Cashed In on 'Buy Now, Pay Later.' Now It Wants to Be a Bank The Game Starts at 8. The Robbery Starts at 8:01 ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
